Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

How can patients and providers best contribute to the HTA process?

556 views

Published on

How can patients and providers best contribute to the HTA process? Anna Nachtnebel, LBI-HTA, Simone Warren, ZIN

Presentation from the 3rd face to face training course for EUnetHTA Stakeholders organised by EUnetHTA JA2 WP2; April 23rd, 2015, Brussels.

Published in: Health & Medicine
  • Be the first to comment

How can patients and providers best contribute to the HTA process?

  1. 1. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands, Diemen, the Netherlands Anna Nachtnebel, Ludwig Boltzmann Institute for HTA, Vienna, Austria WP5 - Applying the HTA Core Model for Rapid Assessment for national adaptation and reporting Third WP2 Face to Face Training Course for EUnetHTA stakeholders, Brussels, 23rd of April 2015
  2. 2. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.euEuropean network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Stakeholder involvement Strand A and Strand B 2
  3. 3. Stakeholder Involvement Strand A Close collaboration with the participating manufacturer Update of the HTA Core Model application for REAs  Stakeholder and public consultation Feedback session with manufacturer about the draft submission template (WP7)
  4. 4. May 8, 2015European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu 4 Stakeholder Involvement Strand B
  5. 5. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Compilation of final project plan  Stakeholder Advisory Group & Stakeholder Forum: informed about upcoming public consultation of project plan, inquiry to suggest external medical experts, patients representatives, identification of manufacturers  Manufacturer(s): informed about upcoming public consultation of project plan, to submit evidence/information on reimbursement status, submission file, scoping meeting(?)  Patients: scoping - selection of relevant outcomes, comparators, draft project plan  Medical experts: scoping - selection of relevant outcomes, comparators, draft project plan  Public: draft project plan Stakeholder involvement - Scoping Phase
  6. 6. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Production of final assessment Manufacturer(s), patients, medical experts: opportunity to comment on second draft of assessment, comments & answers publicly available Further involvement Update of HTA Core Model for Rapid REA Stakeholder involvement - Assessment Phase 6
  7. 7. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu 1. Where do you think stakeholder involvement is most relevant? 2. Could you think of other ways of stakeholder involvement? Plenary session Strand A and Strand B 7
  8. 8. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Thank you! This presentation arises from the EUnetHTA Joint Action 2 which has received funding from the European Union, in the framework of the Health Programme

×